Literature DB >> 12057991

Obligatory role of cyclic adenosine monophosphate response element in cyclooxygenase-2 promoter induction and feedback regulation by inflammatory mediators.

Karsten Schroer1, Ying Zhu, Michael A Saunders, Wu-Guo Deng, Xiao-Ming Xu, Jutta Meyer-Kirchrath, Kenneth K Wu.   

Abstract

BACKGROUND: Cyclooxygenase-2 (COX-2) plays a key role in human inflammatory disorders such as vascular inflammation. COX-2 promoter activity is induced by proinflammatory mediators, but the role of cyclic adenosine monophosphate response element (CRE) in promoter stimulation remains unclear. METHODS AND
RESULTS: Transient transfection of a 0.9-kb COX-2 promoter fragment bearing CRE mutation abrogated COX-2 promoter activity induced by proinflammatory mediators in human endothelial cells and fibroblasts. Dual mutations of CRE and an upstream CCAAT/enhancer binding protein (C/EBP) site did not have an additional effect. Binding of CREB-2, ATF-2, USF-2, and c-Jun transactivators to a wild-type and CRE-mutated oligonucleotide was analyzed by a novel DNA-binding assay. CREB-2 and ATF-2 in nuclear extracts of unstimulated endothelial cells bound to CRE, whereas USF-2 and c-Jun or c-Fos bound to non-CRE sites. CREB-2 and c-Fos binding was increased by phorbol 12-myristate 13-acetate but not tumor necrosis factor-alpha. The binding assay and chromatin immunoprecipitation revealed binding of P300 coactivator to the COX-2 promoter region.
CONCLUSIONS: CRE plays an obligatory role in COX-2 promoter activation by diverse stimuli. CREB-2 and ATF-2 bound to CRE serve as an anchor for P300 interaction with upstream transactivators and downstream transcription machinery.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12057991     DOI: 10.1161/01.cir.0000018127.10968.34

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  21 in total

Review 1.  Loss of CREB regulation of vascular smooth muscle cell quiescence in diabetes.

Authors:  Jane E B Reusch; Peter A Watson
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

2.  Transcriptional regulation of cyclooxygenase-2 in response to proteasome inhibitors involves reactive oxygen species-mediated signaling pathway and recruitment of CCAAT/enhancer-binding protein delta and CREB-binding protein.

Authors:  Jun-Jie Chen; Wei-Chien Huang; Ching-Chow Chen
Journal:  Mol Biol Cell       Date:  2005-09-29       Impact factor: 4.138

3.  Melatonin suppresses macrophage cyclooxygenase-2 and inducible nitric oxide synthase expression by inhibiting p52 acetylation and binding.

Authors:  Wu-Guo Deng; Shao-Tzu Tang; Hui-Ping Tseng; Kenneth K Wu
Journal:  Blood       Date:  2006-04-11       Impact factor: 22.113

4.  Atf3 negatively regulates Ptgs2/Cox2 expression during acute inflammation.

Authors:  Jason Hellmann; Yunan Tang; Michael J Zhang; Tsonwin Hai; Aruni Bhatnagar; Sanjay Srivastava; Matthew Spite
Journal:  Prostaglandins Other Lipid Mediat       Date:  2015-01-22       Impact factor: 3.072

5.  Role of spinal p38alpha and beta MAPK in inflammatory hyperalgesia and spinal COX-2 expression.

Authors:  Bethany L Fitzsimmons; Michela Zattoni; Camilla I Svensson; Joanne Steinauer; Xiao-Ying Hua; Tony L Yaksh
Journal:  Neuroreport       Date:  2010-03-10       Impact factor: 1.837

6.  Transcription factor Ets-1 inhibits glucose-stimulated insulin secretion of pancreatic β-cells partly through up-regulation of COX-2 gene expression.

Authors:  Xiong-Fei Zhang; Yi Zhu; Wen-Biao Liang; Jing-Jing Zhang
Journal:  Endocrine       Date:  2013-11-28       Impact factor: 3.633

Review 7.  Anti-inflammatory properties of lipid oxidation products.

Authors:  Valery N Bochkov; Norbert Leitinger
Journal:  J Mol Med (Berl)       Date:  2003-09-06       Impact factor: 4.599

8.  NALP1 is a transcriptional target for cAMP-response-element-binding protein (CREB) in myeloid leukaemia cells.

Authors:  Cristina Sanz; Maria J Calasanz; Enrique Andreu; Carlos Richard; Felipe Prosper; Jose L Fernandez-Luna
Journal:  Biochem J       Date:  2004-12-01       Impact factor: 3.857

9.  Therapeutic action and underlying mechanisms of a combination of two pentacyclic triterpenes, alpha- and beta-amyrin, in a mouse model of colitis.

Authors:  C E Vitor; C P Figueiredo; D B Hara; A F Bento; T L Mazzuco; J B Calixto
Journal:  Br J Pharmacol       Date:  2009-06-05       Impact factor: 8.739

10.  Several transcription factors regulate COX-2 gene expression in pancreatic beta-cells.

Authors:  Xiongfei Zhang; Jingjing Zhang; Xiaomin Yang; Xiao Han
Journal:  Mol Biol Rep       Date:  2007-05-16       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.